MicroRNA-101 Inhibited Postinfarct Cardiac Fibrosis and Improved Left Ventricular Compliance via the FBJ Osteosarcoma Oncogene/Transforming Growth Factor-β1 Pathway
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-101 Inhibited Postinfarct Cardiac Fibrosis and Improved Left Ventricular Compliance via the FBJ Osteosarcoma Oncogene/Transforming Growth Factor-β1 Pathway
Authors
Keywords
-
Journal
CIRCULATION
Volume 126, Issue 7, Pages 840-850
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-07-19
DOI
10.1161/circulationaha.112.094524
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A microRNA expression signature of osteoclastogenesis
- (2011) T. Sugatani et al. BLOOD
- Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2
- (2010) Zhenwei Pan et al. BRITISH JOURNAL OF PHARMACOLOGY
- MicroRNA-328 Contributes to Adverse Electrical Remodeling in Atrial Fibrillation
- (2010) Yanjie Lu et al. CIRCULATION
- MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion
- (2010) Hui-Ju Wang et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-101-mediated Akt activation and estrogen-independent growth
- (2010) M Sachdeva et al. ONCOGENE
- MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity
- (2009) H. Su et al. CANCER RESEARCH
- Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines
- (2009) Hongli Shan et al. CARDIOVASCULAR RESEARCH
- MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue
- (2009) Sashwati Roy et al. CARDIOVASCULAR RESEARCH
- MicroRNA-320 Is Involved in the Regulation of Cardiac Ischemia/Reperfusion Injury by Targeting Heat-Shock Protein 20
- (2009) Xiao-Ping Ren et al. CIRCULATION
- MicroRNA-133a Protects Against Myocardial Fibrosis and Modulates Electrical Repolarization Without Affecting Hypertrophy in Pressure-Overloaded Adult Hearts
- (2009) Scot J. Matkovich et al. CIRCULATION RESEARCH
- TNF-α induces TGF-β1expression in lung fibroblasts at the transcriptional levelviaAP-1 activation
- (2009) Deborah E. Sullivan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cardiac fibroblasts: At the heart of myocardial remodeling
- (2009) Karen E. Porter et al. PHARMACOLOGY & THERAPEUTICS
- miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy
- (2009) Z. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs: novel regulators in cardiac development and disease
- (2008) T. Thum et al. CARDIOVASCULAR RESEARCH
- The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure
- (2008) Vijay Divakaran et al. CIRCULATION RESEARCH
- miR-133 and miR-30 Regulate Connective Tissue Growth Factor
- (2008) Rudy F. Duisters et al. CIRCULATION RESEARCH
- MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma
- (2008) Shuai Li et al. HEPATOLOGY
- miRNAs at the heart of the matter
- (2008) Zhiguo Wang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
- (2008) Thomas Thum et al. NATURE
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
- (2008) E. van Rooij et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
- (2008) S. Varambally et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started